Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

HIGHLIGHTS

• who: Jessica E. Green from the The trial will be conducted at a dedicated clinical trials facility at University Hospital Geelong, VictoriaThis space includes appropriate consultation spaces and onsite equipment for intervention delivery and the collection of biological samples. This study will consist of , study appointments, six of which are in-person and four via telehealth (see Table , and Fig., ). The collection of blood samples will be performed by a qualified research nurse or phlebotomist, where markers of cardiovascular and metabolic disease risk (e_g lipids, HbA1c, and blood glucose) will be assayed. Additional blood samples will be . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.